Some Chinese firms claim U.S. semiconductor imports exempt from additional tariffs
ByAinvest
Thursday, Apr 24, 2025 10:58 pm ET1min read
Some Chinese firms claim U.S. semiconductor imports exempt from additional tariffs
Chinese firms are reportedly claiming that certain U.S. semiconductor imports are exempt from additional tariffs, according to recent developments in the ongoing trade tensions between the United States and China. This comes as the Chinese government has been actively seeking ways to mitigate the impact of U.S. tariffs on its economy.In a recent announcement, the Chinese Ministry of Commerce stated that a significant number of U.S. semiconductor imports are eligible for tariff exemptions under specific conditions. The ministry cited a clause in the U.S.-China trade agreement that allows for exemptions on certain goods, including semiconductors, if they meet specific criteria related to technology and innovation.
The announcement follows a series of stock buyback plans by Chinese companies aimed at offsetting the market impact from U.S. tariffs. As of April 24, 2025, buyback plans announced in China have reached the highest level since a stock rout in February 2024, totaling 44.1 billion yuan ($6 billion) [2]. This is a sign that Chinese companies are putting in concerted efforts to stabilize investor sentiment and offset the negative effects of the trade war.
The U.S. government, under the administration of President Donald Trump, has imposed tariffs of up to 145% on Chinese imports. In contrast, South Korean exports to the U.S. currently face a relatively moderate 10% tariff, as part of a 90-day suspension of reciprocal duties [1]. To exploit this disparity, Chinese firms have been allegedly disguising the origin of their products, routing them through South Korea and falsely labeling them as locally made. This practice has been a significant concern for South Korean authorities, who have warned that such practices damage South Korea's credibility in global markets.
The news comes as trade negotiations between South Korea and the U.S. are ongoing. A delegation from South Korea is meeting with its U.S. counterparts on Thursday to discuss various issues, including shipbuilding, energy, and defense costs [1]. The Trump administration is pushing for stronger measures during the talks, urging allies not to serve as backdoors for Chinese products.
China, however, has rejected unilateral pressure, vowing to take "reciprocal countermeasures" if its interests are compromised. The White House may consider reducing tariffs to between 50-65%, but any reductions will depend on progress in direct talks with Beijing.
References:
[1] https://www.business-standard.com/world-news/made-in-korea-mislabel-chinese-goods-bypass-us-trump-tariff-125042400941_1.html
[2] https://www.bloomberg.com/news/articles/2025-04-24/china-s-stock-buyback-plans-hit-14-month-high-as-firms-pitch-in
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet